PLTP and metabolic syndrome: ppGalNAc-T2 has been shown to regulate high-density lipoprotein cholesterol (HDL-C) metabolism by O-glycosylation of phospholipid transfer protein (PLTP) and is suggested to associate with dyslipidemia and coronary artery disease (CAD) [40,41].